Your search returned 24 results.

Results
	1.	Guidelines for the indications for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_161 Add to cart (remove)
	2.	Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_235 Add to cart (remove)
	3.	Guidelines for the prescribed activity for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_236 Add to cart (remove)
	4.	Guidelines for the prescribed activity for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_162 Add to cart (remove)
	5.	Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Guan H, Van Nostrand D, Li Y, Teng W, Khorjekar G Local accession number: 2013_7 Add to cart (remove)
	6.	Number of Foci of Functioning Thyroid Tissue Remaining after Thyroidectomy for Differentiated Thyroid Cancer: Institutional Experience. MedStar authors: Khorjekar, Gauri Kulkarni, Kanchan Mete, Mihriye Van Nostrand, Douglas PMID: 28553178 Year: 2017 Citation: World Journal of Nuclear Medicine. 16(2):122-125, 2017 Apr-Jun Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Khorjekar G, Kulkarni K, Mete M, Van Nostrand D DOI: https://dx.doi.org/10.4103/1450-1147.203066 Add to cart (remove)
	7.	124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer. MedStar authors: Atkins, Frank Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G Local accession number: 2013_166 Add to cart (remove)
	8.	Evaluation of lithium as adjunctive treatment of 131I therapy for differentiated thyroid cancer: an educational exhibit MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Van Nostrand D, Khorjekar G, Elboga U, Guan H, Wartofsky L Local accession number: 2013_7 Add to cart (remove)
	9.	#Alpharadinr #(Xofigor) in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Duong E, Orquiza M, Khorjekar G, Van Nostrand D Local accession number: 2013_159 Add to cart (remove)
	10.	Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Duong E, Orquiza M, Khorjekar G, Van Nostrand D Local accession number: 2013_233 Add to cart (remove)
	11.	124I-NaI PET/CT based 3-D radiobiological Dosimetry (3D-RD) for 131I-NaI therapy of metastatic well-differentiated thyroid cancer. MedStar authors: Atkins, Frank Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Atkins F, Khorjekar G, Orquiza MD Local accession number: 2013_2 Add to cart (remove)
	12.	Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Duong E, Khorjekar G, Van Nostrand D Local accession number: 2013_7 Add to cart (remove)
	13.	Characterization of salivary gland side effects secondary to 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey for intermediate and long term results MedStar authors: Hall, Jordan Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Hall J, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G Local accession number: 2013_7 Add to cart (remove)
	14.	Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results. MedStar authors: Hall, Jordan Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza MH, Hall JP, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G Local accession number: 2013_2 Add to cart (remove)
	15.	A comparison of the frequency, duration and severity of salivary side effects in differentiated thyroid cancer patients treated with <1.85 Gbq (50 Mci) Versus >7.4 Gbq (200 Mci) I-131 therapy: an analysis of the ThyCa National Survey. MedStar authors: Brennan, Michael T Hall, Jordan Khorjekar, Gauri Van Nostrand, Douglas Wu, Di Zeymo, Alexander Year: 2017 Citation: Unpublished 2017/10/03 Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bloom G Brennan MT Hall J Khorjekar G McIver B Van Nostrand D Wu D Zeymo A Local accession number: A2017_050 Add to cart (remove)
	16.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for metastatic differentiated thyroid cancer (DTC) MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Washington Cancer Institute Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_4 Add to cart (remove)
	17.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for Metastatic Differentiated Thyroid Cancer (DTC). MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Orquiza MD, Atkins F, Mete M, Garcia C, Wartofsky L, Van Nostrand D Local accession number: 2013_2 Add to cart (remove)
	18.	Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer. MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_16 Add to cart (remove)
	19.	Survival rate in differentiated thyroid cancer patients with bone metastases. MedStar authors: Atkins, Francis Burman, Kenneth D Khorjekar, Gauri R Kulkarni, Kanchan Moreau, Shari Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Endocrinology Medicine/General Internal Medicine Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L Local accession number: 2014.1_132 Add to cart (remove)
	20.	Characterization of sialoadenitis (SA) after administration of continuous sialogogues (SGs) during the day and night after 131I therapy (tx) MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri Kulkarni, Kanchan Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D Local accession number: 2013_7 Add to cart (remove)
	21.	Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration. MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri R Kulkarni, Kanchan Orquiza, Michael H Schneider, M Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Endocrinology Medicine/General Internal Medicine Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D Local accession number: 2014.1_133 Add to cart (remove)
	22.	Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?. MedStar authors: Atkins, Francis Burman, Kenneth Garcia, Carlos Khorjekar, Gauri R Mete, Mihriye Moreau, Shari O'Neil, Jeff Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard PMID: 24820222 Citation: Thyroid. 24(9):1394-9, 2014 Sep. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Atkins FB, Burman K, Garcia C, Khorjekar GR, Mete M, Moreau S, O'Neil J, Orquiza MH, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.1089/thy.2013.0713 Add to cart (remove)
	23.	Altered taste after 131I therapy: the frequency, time of onset, severity, and duration MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri R Kulkarni, Kanchan Orquiza, Michael H Schneider, M Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Endocrinology Medicine/General Internal Medicine Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D Local accession number: 2014.1_134 Add to cart (remove)
	24.	Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET.[Erratum appears in J Nucl Med. 2012 May;53(5):830] MedStar authors: Atkins, Frank B Burman, Kenneth D Chennupati, Shyam P Kharazi, Pejman Khorjekar, Gauri R Mete, Mihriye Moreau, Shari O'Neil, Jeff Van Nostrand, Douglas Wartofsky, Leonard PMID: 22315442 Year: 2012 Citation: Journal of Nuclear Medicine. 53(3):359-62, 2012 Mar. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Atkins FB, Burman KD, Chennupati SP, Kharazi P, Khorjekar GR, Mete M, Moreau S, O'Neil J, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.2967/jnumed.111.096016 Add to cart (remove)

Refine your search

Authors

Item types

Topics

Collections

Languages

Your search returned 24 results.